IKZF1 and acute lymphoblastic leukemia: However, large discrepancies are noted with respect to concomitant abnormalities of IKZF1 deletion and the prognostic value in different reports (14–19), and whether IKZF1plus achieves an equally superior prognostic performance in all B-ALL patients remains unknown.